nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0432	0.061	CbGbCtD
Zileuton—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0407	0.0574	CbGbCtD
Zileuton—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0407	0.0574	CbGbCtD
Zileuton—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.039	0.055	CbGbCtD
Zileuton—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0368	0.0519	CbGbCtD
Zileuton—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0366	0.0517	CbGbCtD
Zileuton—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0366	0.0517	CbGbCtD
Zileuton—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0331	0.0467	CbGbCtD
Zileuton—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0331	0.0467	CbGbCtD
Zileuton—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0308	0.0435	CbGbCtD
Zileuton—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0286	0.0404	CbGbCtD
Zileuton—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0279	0.0393	CbGbCtD
Zileuton—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0278	0.0392	CbGbCtD
Zileuton—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0251	0.0354	CbGbCtD
Zileuton—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0251	0.0354	CbGbCtD
Zileuton—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0241	0.034	CbGbCtD
Zileuton—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0227	0.032	CbGbCtD
Zileuton—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0213	0.0301	CbGbCtD
Zileuton—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0213	0.0301	CbGbCtD
Zileuton—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0193	0.0272	CbGbCtD
Zileuton—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0193	0.0272	CbGbCtD
Zileuton—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0166	0.0235	CbGbCtD
Zileuton—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0161	0.0228	CbGbCtD
Zileuton—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0146	0.0206	CbGbCtD
Zileuton—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0146	0.0206	CbGbCtD
Zileuton—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.014	0.0197	CbGbCtD
Zileuton—LTB4R—skin of body—acquired immunodeficiency syndrome	0.00394	0.0619	CbGeAlD
Zileuton—EPHX2—retina—acquired immunodeficiency syndrome	0.0033	0.0519	CbGeAlD
Zileuton—LTB4R—lymphoid tissue—acquired immunodeficiency syndrome	0.00319	0.0501	CbGeAlD
Zileuton—LTB4R—blood—acquired immunodeficiency syndrome	0.00301	0.0472	CbGeAlD
Zileuton—LTB4R—bone marrow—acquired immunodeficiency syndrome	0.00291	0.0457	CbGeAlD
Zileuton—LTB4R—vagina—acquired immunodeficiency syndrome	0.00279	0.0437	CbGeAlD
Zileuton—LTB4R—lung—acquired immunodeficiency syndrome	0.00263	0.0414	CbGeAlD
Zileuton—EPHX2—blood—acquired immunodeficiency syndrome	0.00221	0.0347	CbGeAlD
Zileuton—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.00212	0.0333	CbGeAlD
Zileuton—EPHX2—vagina—acquired immunodeficiency syndrome	0.00205	0.0322	CbGeAlD
Zileuton—EPHX2—lung—acquired immunodeficiency syndrome	0.00194	0.0304	CbGeAlD
Zileuton—LTB4R—brain—acquired immunodeficiency syndrome	0.00186	0.0293	CbGeAlD
Zileuton—LTB4R—lymph node—acquired immunodeficiency syndrome	0.0018	0.0283	CbGeAlD
Zileuton—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00167	0.0263	CbGeAlD
Zileuton—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00163	0.0257	CbGeAlD
Zileuton—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00159	0.025	CbGeAlD
Zileuton—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00145	0.0228	CbGeAlD
Zileuton—ALOX5—lymphoid tissue—acquired immunodeficiency syndrome	0.00141	0.0221	CbGeAlD
Zileuton—ALOX5—digestive system—acquired immunodeficiency syndrome	0.00139	0.0218	CbGeAlD
Zileuton—EPHX2—brain—acquired immunodeficiency syndrome	0.00137	0.0215	CbGeAlD
Zileuton—EPHX2—lymph node—acquired immunodeficiency syndrome	0.00133	0.0208	CbGeAlD
Zileuton—ALOX5—blood—acquired immunodeficiency syndrome	0.00132	0.0208	CbGeAlD
Zileuton—ALOX5—bone marrow—acquired immunodeficiency syndrome	0.00128	0.0201	CbGeAlD
Zileuton—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00121	0.019	CbGeAlD
Zileuton—ALOX5—lung—acquired immunodeficiency syndrome	0.00116	0.0182	CbGeAlD
Zileuton—ALOX5—nervous system—acquired immunodeficiency syndrome	0.00108	0.0169	CbGeAlD
Zileuton—ALOX5—central nervous system—acquired immunodeficiency syndrome	0.00104	0.0163	CbGeAlD
Zileuton—ALOX5—brain—acquired immunodeficiency syndrome	0.000822	0.0129	CbGeAlD
Zileuton—ALOX5—lymph node—acquired immunodeficiency syndrome	0.000794	0.0125	CbGeAlD
Zileuton—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000698	0.011	CbGeAlD
Zileuton—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000644	0.0101	CbGeAlD
Zileuton—CYP1A2—blood—acquired immunodeficiency syndrome	0.000614	0.00964	CbGeAlD
Zileuton—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000611	0.0096	CbGeAlD
Zileuton—CYP2C9—blood—acquired immunodeficiency syndrome	0.000582	0.00915	CbGeAlD
Zileuton—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000558	0.00877	CbGeAlD
Zileuton—CYP1A2—lung—acquired immunodeficiency syndrome	0.000538	0.00845	CbGeAlD
Zileuton—PTGS1—blood—acquired immunodeficiency syndrome	0.000532	0.00835	CbGeAlD
Zileuton—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000512	0.00805	CbGeAlD
Zileuton—PTGS1—vagina—acquired immunodeficiency syndrome	0.000493	0.00774	CbGeAlD
Zileuton—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00047	0.00212	CcSEcCtD
Zileuton—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000469	0.00212	CcSEcCtD
Zileuton—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000468	0.00211	CcSEcCtD
Zileuton—Pain—Nevirapine—acquired immunodeficiency syndrome	0.000467	0.00211	CcSEcCtD
Zileuton—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000466	0.00732	CbGeAlD
Zileuton—PTGS1—lung—acquired immunodeficiency syndrome	0.000466	0.00732	CbGeAlD
Zileuton—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000465	0.0021	CcSEcCtD
Zileuton—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.000465	0.0021	CcSEcCtD
Zileuton—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000464	0.00209	CcSEcCtD
Zileuton—Tension—Delavirdine—acquired immunodeficiency syndrome	0.000463	0.00209	CcSEcCtD
Zileuton—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.00046	0.00208	CcSEcCtD
Zileuton—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000458	0.00207	CcSEcCtD
Zileuton—Ill-defined disorder—Efavirenz—acquired immunodeficiency syndrome	0.000457	0.00206	CcSEcCtD
Zileuton—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000456	0.00206	CcSEcCtD
Zileuton—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000455	0.00206	CcSEcCtD
Zileuton—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000455	0.00205	CcSEcCtD
Zileuton—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000452	0.00204	CcSEcCtD
Zileuton—Pain—Stavudine—acquired immunodeficiency syndrome	0.000451	0.00203	CcSEcCtD
Zileuton—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000451	0.00203	CcSEcCtD
Zileuton—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00045	0.00203	CcSEcCtD
Zileuton—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000448	0.00202	CcSEcCtD
Zileuton—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000447	0.00202	CcSEcCtD
Zileuton—Malaise—Efavirenz—acquired immunodeficiency syndrome	0.000445	0.00201	CcSEcCtD
Zileuton—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000444	0.002	CcSEcCtD
Zileuton—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000444	0.002	CcSEcCtD
Zileuton—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000444	0.002	CcSEcCtD
Zileuton—CYP3A4—blood—acquired immunodeficiency syndrome	0.000444	0.00697	CbGeAlD
Zileuton—Pain—Abacavir—acquired immunodeficiency syndrome	0.000444	0.002	CcSEcCtD
Zileuton—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.000439	0.00198	CcSEcCtD
Zileuton—Ill-defined disorder—Delavirdine—acquired immunodeficiency syndrome	0.000438	0.00197	CcSEcCtD
Zileuton—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000435	0.00196	CcSEcCtD
Zileuton—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000433	0.00196	CcSEcCtD
Zileuton—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000432	0.00678	CbGeAlD
Zileuton—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000431	0.00195	CcSEcCtD
Zileuton—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00043	0.00194	CcSEcCtD
Zileuton—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000429	0.00194	CcSEcCtD
Zileuton—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000428	0.00193	CcSEcCtD
Zileuton—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000428	0.00193	CcSEcCtD
Zileuton—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00192	CcSEcCtD
Zileuton—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000424	0.00191	CcSEcCtD
Zileuton—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000423	0.00191	CcSEcCtD
Zileuton—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Zileuton—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Zileuton—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Zileuton—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Zileuton—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00042	0.00189	CcSEcCtD
Zileuton—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000419	0.00189	CcSEcCtD
Zileuton—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000419	0.00189	CcSEcCtD
Zileuton—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000418	0.00188	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000417	0.00188	CcSEcCtD
Zileuton—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000417	0.00188	CcSEcCtD
Zileuton—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000416	0.00188	CcSEcCtD
Zileuton—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000416	0.00653	CbGeAlD
Zileuton—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000415	0.00187	CcSEcCtD
Zileuton—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000415	0.00187	CcSEcCtD
Zileuton—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000414	0.00187	CcSEcCtD
Zileuton—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000414	0.00187	CcSEcCtD
Zileuton—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000412	0.00186	CcSEcCtD
Zileuton—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00041	0.00185	CcSEcCtD
Zileuton—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000407	0.00184	CcSEcCtD
Zileuton—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.000405	0.00183	CcSEcCtD
Zileuton—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000403	0.00182	CcSEcCtD
Zileuton—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000402	0.00181	CcSEcCtD
Zileuton—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.00181	CcSEcCtD
Zileuton—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.00181	CcSEcCtD
Zileuton—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000402	0.00181	CcSEcCtD
Zileuton—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000397	0.00179	CcSEcCtD
Zileuton—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000395	0.00178	CcSEcCtD
Zileuton—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000395	0.00178	CcSEcCtD
Zileuton—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000395	0.00178	CcSEcCtD
Zileuton—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00177	CcSEcCtD
Zileuton—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000393	0.00177	CcSEcCtD
Zileuton—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000392	0.00177	CcSEcCtD
Zileuton—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000392	0.00177	CcSEcCtD
Zileuton—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00039	0.00176	CcSEcCtD
Zileuton—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000389	0.00176	CcSEcCtD
Zileuton—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000389	0.00176	CcSEcCtD
Zileuton—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000388	0.00175	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000388	0.00175	CcSEcCtD
Zileuton—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000386	0.00174	CcSEcCtD
Zileuton—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000386	0.00174	CcSEcCtD
Zileuton—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000385	0.00174	CcSEcCtD
Zileuton—Rash—Didanosine—acquired immunodeficiency syndrome	0.000383	0.00173	CcSEcCtD
Zileuton—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000382	0.00173	CcSEcCtD
Zileuton—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000382	0.00172	CcSEcCtD
Zileuton—Headache—Didanosine—acquired immunodeficiency syndrome	0.00038	0.00172	CcSEcCtD
Zileuton—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000379	0.00171	CcSEcCtD
Zileuton—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000379	0.00171	CcSEcCtD
Zileuton—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000377	0.0017	CcSEcCtD
Zileuton—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000375	0.00169	CcSEcCtD
Zileuton—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000374	0.00169	CcSEcCtD
Zileuton—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000373	0.00168	CcSEcCtD
Zileuton—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000373	0.00168	CcSEcCtD
Zileuton—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000372	0.00168	CcSEcCtD
Zileuton—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00168	CcSEcCtD
Zileuton—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00168	CcSEcCtD
Zileuton—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00168	CcSEcCtD
Zileuton—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000368	0.00166	CcSEcCtD
Zileuton—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000367	0.00166	CcSEcCtD
Zileuton—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.00166	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000367	0.00165	CcSEcCtD
Zileuton—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000364	0.00164	CcSEcCtD
Zileuton—Pain—Indinavir—acquired immunodeficiency syndrome	0.000364	0.00164	CcSEcCtD
Zileuton—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.00164	CcSEcCtD
Zileuton—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000364	0.00164	CcSEcCtD
Zileuton—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000362	0.00163	CcSEcCtD
Zileuton—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000362	0.00163	CcSEcCtD
Zileuton—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00163	CcSEcCtD
Zileuton—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000361	0.00566	CbGeAlD
Zileuton—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00036	0.00163	CcSEcCtD
Zileuton—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00036	0.00163	CcSEcCtD
Zileuton—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000358	0.00161	CcSEcCtD
Zileuton—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00161	CcSEcCtD
Zileuton—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00161	CcSEcCtD
Zileuton—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000357	0.00161	CcSEcCtD
Zileuton—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000355	0.0016	CcSEcCtD
Zileuton—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000354	0.0016	CcSEcCtD
Zileuton—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00159	CcSEcCtD
Zileuton—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000351	0.00158	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000351	0.00158	CcSEcCtD
Zileuton—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000349	0.00158	CcSEcCtD
Zileuton—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000348	0.00157	CcSEcCtD
Zileuton—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00157	CcSEcCtD
Zileuton—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000347	0.00157	CcSEcCtD
Zileuton—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000347	0.00545	CbGeAlD
Zileuton—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000347	0.00157	CcSEcCtD
Zileuton—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.00155	CcSEcCtD
Zileuton—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.00155	CcSEcCtD
Zileuton—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000344	0.00155	CcSEcCtD
Zileuton—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000344	0.00155	CcSEcCtD
Zileuton—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000343	0.00155	CcSEcCtD
Zileuton—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.00154	CcSEcCtD
Zileuton—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000342	0.00154	CcSEcCtD
Zileuton—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00154	CcSEcCtD
Zileuton—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00154	CcSEcCtD
Zileuton—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000341	0.00154	CcSEcCtD
Zileuton—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00153	CcSEcCtD
Zileuton—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000338	0.00153	CcSEcCtD
Zileuton—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000337	0.00152	CcSEcCtD
Zileuton—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000337	0.00152	CcSEcCtD
Zileuton—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000336	0.00152	CcSEcCtD
Zileuton—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000335	0.00151	CcSEcCtD
Zileuton—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000333	0.0015	CcSEcCtD
Zileuton—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000333	0.0015	CcSEcCtD
Zileuton—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000332	0.0015	CcSEcCtD
Zileuton—Rash—Stavudine—acquired immunodeficiency syndrome	0.000332	0.0015	CcSEcCtD
Zileuton—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000332	0.0015	CcSEcCtD
Zileuton—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.0015	CcSEcCtD
Zileuton—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000331	0.00149	CcSEcCtD
Zileuton—Headache—Stavudine—acquired immunodeficiency syndrome	0.00033	0.00149	CcSEcCtD
Zileuton—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00033	0.00149	CcSEcCtD
Zileuton—PTGS1—brain—acquired immunodeficiency syndrome	0.00033	0.00518	CbGeAlD
Zileuton—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00149	CcSEcCtD
Zileuton—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000329	0.00149	CcSEcCtD
Zileuton—Rash—Abacavir—acquired immunodeficiency syndrome	0.000327	0.00148	CcSEcCtD
Zileuton—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000327	0.00148	CcSEcCtD
Zileuton—Headache—Abacavir—acquired immunodeficiency syndrome	0.000325	0.00147	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000324	0.00146	CcSEcCtD
Zileuton—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000324	0.00146	CcSEcCtD
Zileuton—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000324	0.00146	CcSEcCtD
Zileuton—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00145	CcSEcCtD
Zileuton—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00032	0.00144	CcSEcCtD
Zileuton—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000319	0.00501	CbGeAlD
Zileuton—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.00144	CcSEcCtD
Zileuton—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000317	0.00143	CcSEcCtD
Zileuton—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00143	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000316	0.0538	CbGpPWpGaD
Zileuton—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000314	0.00142	CcSEcCtD
Zileuton—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000314	0.00142	CcSEcCtD
Zileuton—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00141	CcSEcCtD
Zileuton—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000313	0.00141	CcSEcCtD
Zileuton—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000313	0.00141	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000312	0.00141	CcSEcCtD
Zileuton—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.0014	CcSEcCtD
Zileuton—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000308	0.00139	CcSEcCtD
Zileuton—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00139	CcSEcCtD
Zileuton—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.00138	CcSEcCtD
Zileuton—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000305	0.00137	CcSEcCtD
Zileuton—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00137	CcSEcCtD
Zileuton—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00137	CcSEcCtD
Zileuton—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000304	0.00137	CcSEcCtD
Zileuton—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000303	0.00137	CcSEcCtD
Zileuton—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00136	CcSEcCtD
Zileuton—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000301	0.00136	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.00134	CcSEcCtD
Zileuton—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00134	CcSEcCtD
Zileuton—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00133	CcSEcCtD
Zileuton—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00133	CcSEcCtD
Zileuton—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00132	CcSEcCtD
Zileuton—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00132	CcSEcCtD
Zileuton—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00132	CcSEcCtD
Zileuton—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000291	0.00131	CcSEcCtD
Zileuton—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.00131	CcSEcCtD
Zileuton—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000291	0.00131	CcSEcCtD
Zileuton—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000289	0.0013	CcSEcCtD
Zileuton—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000288	0.0013	CcSEcCtD
Zileuton—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.0013	CcSEcCtD
Zileuton—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000287	0.00129	CcSEcCtD
Zileuton—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00128	CcSEcCtD
Zileuton—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000284	0.00128	CcSEcCtD
Zileuton—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.00128	CcSEcCtD
Zileuton—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00127	CcSEcCtD
Zileuton—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00127	CcSEcCtD
Zileuton—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000282	0.00127	CcSEcCtD
Zileuton—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00127	CcSEcCtD
Zileuton—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00126	CcSEcCtD
Zileuton—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00028	0.00126	CcSEcCtD
Zileuton—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.00124	CcSEcCtD
Zileuton—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Zileuton—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Zileuton—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000272	0.00123	CcSEcCtD
Zileuton—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00122	CcSEcCtD
Zileuton—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000271	0.00122	CcSEcCtD
Zileuton—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00122	CcSEcCtD
Zileuton—Rash—Indinavir—acquired immunodeficiency syndrome	0.000269	0.00121	CcSEcCtD
Zileuton—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000268	0.00121	CcSEcCtD
Zileuton—Headache—Indinavir—acquired immunodeficiency syndrome	0.000267	0.0012	CcSEcCtD
Zileuton—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.0012	CcSEcCtD
Zileuton—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00119	CcSEcCtD
Zileuton—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00118	CcSEcCtD
Zileuton—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00026	0.00117	CcSEcCtD
Zileuton—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00117	CcSEcCtD
Zileuton—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.00115	CcSEcCtD
Zileuton—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000255	0.00115	CcSEcCtD
Zileuton—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000254	0.00114	CcSEcCtD
Zileuton—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.00114	CcSEcCtD
Zileuton—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000253	0.00114	CcSEcCtD
Zileuton—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Zileuton—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Zileuton—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00114	CcSEcCtD
Zileuton—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.0011	CcSEcCtD
Zileuton—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000244	0.0011	CcSEcCtD
Zileuton—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.0011	CcSEcCtD
Zileuton—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000243	0.00109	CcSEcCtD
Zileuton—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00109	CcSEcCtD
Zileuton—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Zileuton—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00109	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00024	0.041	CbGpPWpGaD
Zileuton—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000239	0.00108	CcSEcCtD
Zileuton—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.00106	CcSEcCtD
Zileuton—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00106	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.000233	0.0397	CbGpPWpGaD
Zileuton—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00104	CcSEcCtD
Zileuton—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000229	0.00103	CcSEcCtD
Zileuton—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00102	CcSEcCtD
Zileuton—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.00102	CcSEcCtD
Zileuton—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00101	CcSEcCtD
Zileuton—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.00101	CcSEcCtD
Zileuton—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000224	0.00101	CcSEcCtD
Zileuton—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00101	CcSEcCtD
Zileuton—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000983	CcSEcCtD
Zileuton—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.000975	CcSEcCtD
Zileuton—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000975	CcSEcCtD
Zileuton—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000974	CcSEcCtD
Zileuton—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.000969	CcSEcCtD
Zileuton—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.000954	CcSEcCtD
Zileuton—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000938	CcSEcCtD
Zileuton—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.00093	CcSEcCtD
Zileuton—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000929	CcSEcCtD
Zileuton—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000924	CcSEcCtD
Zileuton—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000918	CcSEcCtD
Zileuton—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000876	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000191	0.0326	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000173	0.0295	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000162	0.0275	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000148	0.0253	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000146	0.0248	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000132	0.0224	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000125	0.0213	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000123	0.021	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000118	0.0201	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000117	0.02	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000107	0.0182	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.0001	0.0171	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.0001	0.0171	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	9.77e-05	0.0167	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9e-05	0.0153	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	8.69e-05	0.0148	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.25e-05	0.0141	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.14e-05	0.0139	CbGpPWpGaD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.04e-05	0.0137	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—TAT—acquired immunodeficiency syndrome	7.77e-05	0.0132	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	7.65e-05	0.013	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	7.65e-05	0.013	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	7.65e-05	0.013	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	7.53e-05	0.0128	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.48e-05	0.0127	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.29e-05	0.0124	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	6.89e-05	0.0117	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	6.87e-05	0.0117	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.76e-05	0.0115	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—AGPS—acquired immunodeficiency syndrome	6.61e-05	0.0113	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	6.58e-05	0.0112	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	6.33e-05	0.0108	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	6.14e-05	0.0105	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	5.82e-05	0.00992	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	5.46e-05	0.0093	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	5.31e-05	0.00904	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.25e-05	0.00894	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	5.11e-05	0.0087	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.62e-05	0.00787	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.6e-05	0.00784	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	4.45e-05	0.00758	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.42e-05	0.00752	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.42e-05	0.00752	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.39e-05	0.00748	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.32e-05	0.00737	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.32e-05	0.00737	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—TAT—acquired immunodeficiency syndrome	4.32e-05	0.00736	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.18e-05	0.00712	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.99e-05	0.0068	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.98e-05	0.00678	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.93e-05	0.00669	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.93e-05	0.00669	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—AGPS—acquired immunodeficiency syndrome	3.68e-05	0.00626	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	3.59e-05	0.00612	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.58e-05	0.0061	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.29e-05	0.00561	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	3.27e-05	0.00557	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.24e-05	0.00552	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.16e-05	0.00538	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.04e-05	0.00518	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.99e-05	0.00509	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	2.98e-05	0.00508	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.96e-05	0.00505	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.94e-05	0.00501	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.73e-05	0.00465	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.69e-05	0.00459	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.47e-05	0.0042	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.32e-05	0.00395	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.32e-05	0.00395	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—TAT—acquired immunodeficiency syndrome	2.3e-05	0.00392	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	2.25e-05	0.00383	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	2e-05	0.00341	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.95e-05	0.00333	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	1.93e-05	0.00329	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.88e-05	0.0032	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	1.87e-05	0.00319	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.77e-05	0.00301	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.74e-05	0.00296	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.71e-05	0.00292	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.69e-05	0.00288	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.61e-05	0.00274	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.59e-05	0.00272	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.59e-05	0.00271	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.56e-05	0.00265	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.56e-05	0.00265	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.46e-05	0.00248	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	1.46e-05	0.00248	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ALB—acquired immunodeficiency syndrome	1.36e-05	0.00231	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	9.85e-06	0.00168	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.19e-06	0.00157	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.14e-06	0.00156	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9e-06	0.00153	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	8.42e-06	0.00143	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	8.38e-06	0.00143	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—acquired immunodeficiency syndrome	7.54e-06	0.00128	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	7.34e-06	0.00125	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	7.16e-06	0.00122	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	6.5e-06	0.00111	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	5.53e-06	0.000941	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.4e-06	0.00092	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—acquired immunodeficiency syndrome	4.01e-06	0.000683	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.86e-06	0.000657	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.3e-06	0.000562	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	3.27e-06	0.000557	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.72e-06	0.000293	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.47e-06	0.00025	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	1.13e-06	0.000193	CbGpPWpGaD
